Pharmacology of the Meglitinide Analogs
- 1 January 2003
- journal article
- Published by Springer Science and Business Media LLC in Treatments in Endocrinology
- Vol. 2 (6), 401-414
- https://doi.org/10.2165/00024677-200302060-00004
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- RepaglinideDrugs, 2001
- Meglitinide Analogues in the Treatment of Type 2 Diabetes MellitusDrugs & Aging, 2000
- Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.Diabetes Care, 2000
- Single‐Dose Pharmacokinetics of Repaglinide in Subjects with Chronic Liver DiseaseThe Journal of Clinical Pharmacology, 2000
- REPAGLINIDE PRESERVES NUTRIENT-STIMULATED BIOSYNTHETIC ACTIVITY IN RAT PANCREATIC ISLETSPharmacological Research, 1996
- Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate I. Secretory and cationic aspectsGeneral Pharmacology: The Vascular System, 1995
- Insulinotropic action of (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinyl-carbonyl) propionate II. Ionophoretic and conformational aspectsGeneral Pharmacology: The Vascular System, 1995
- Stimulation of Insulin Release by Non-Sulfonylurea Hypoglycemic Agents: The Meglitinide FamilyHormone and Metabolic Research, 1995
- Normalization of impaired glucose tolerance by the short-acting hypoglycemic agent calcium (2S)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate (KAD-1229) in non-insulin-dependent diabetes mellitus ratsCanadian Journal of Physiology and Pharmacology, 1995
- Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic β-cell line, MIN 6 cellEuropean Journal of Pharmacology: Molecular Pharmacology, 1994